National Pharmaceutical Congress II
November 28, 2007
The National Pharmaceutical Congress of 2007 was divided into three rapid-fire sessions entitled The Operating Climate, The Patient/Physician Climate, and The Innovation/Creativity Climate. These sessions provided the opportunity for leaders in the life sciences industry to present reflections, ideas and innovations.
Rapid Fire Session I: The Operating Climate
The Pangaea Group of Companies
Canada's Research-Based Pharmaceutical Companies (Rx&D)
The JBL Group
Solvay Pharma Inc.
P&G Pharmaceuticals Canada
Oxford Debate I
Moderator: Dr. Shafiq Qaadri, MPP,
Parliamentary Assistant to the Minister of Health Promotion
For the affirmative: Dr. David R. Greenberg, D. Dave HealthCare Solutions
For the negative: Marc Lalande,
Council for Continuing Pharmaceutical Education (CCPE)
Resolved: This house believes the role of the professional pharmaceutical representatives is outmoded and recommends an industry-wide reduction of drug reps by 20 percent
Nutritional Break, Networking
Rapid Fire Session II: The Patient/Physician Climate
IMS Health Canada
Novo Nordisk Canada Inc.
Merck Research Laboratories
Pharmaceutical Advertising Advisory Board (PAAB)
Rapid Fire Session III: The Innovation/Creativity Climate
Paladin Labs Inc.
Lundbeck Canada Inc.
Stiefel Canada Inc.
Concluding Remarks and Summary
Canadian Healthcare Marketing Hall of Fame Reception
Canadian Healthcare Marketing Hall of Fame Gala Luncheon